Thursday, January 27, 2022 7:04:40 AM
Progressive Care Announces Partnership with Leader in Automated Analytics
MIAMI, FL – January 27, 2022 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company has partnered with Aimpoint Digital (www.aimpointdigital.com), a premier Alteryx consulting partner, to accelerate value realization from their analytic investments. Alteryx (www.alteryx.com) is an Analytics Automation company that delivers breakthrough business outcomes via its user-friendly, code free platform.
“Thanks to our partnership with Aimpoint Digital, we were able to not only to get the most of our Alteryx investment, but also get a wide knowledge base related to best practices, infrastructure, and processes. Our data team at Progressive Care has become more agile in working with any company equipped with API data transfer capabilities,” stated Carlos Rangel, Head of Digital Transformation at Progressive Care. “Without question, having access to the large community of developers at Alteryx added to Aimpoint Digital’s support simplifies how we handle large datasets as it allows us to quickly and seamlesslyidentify errors and troubleshoot key systems.”
Management notes that Alteryx enables the Progressive Careteam to handle large data sets to identify insights related to prescription delivery, including how often the Company serviceseach patient, which medications patients receive, and the key dates of fulfillment for each prescription customer. Alteryx alsoprovides for a 35% improvement in database run-time forpharmacy data reporting.
Alteryx has also allowed the Company’s data management team to identify 340B claims on its SQL server and to automate reports showing a comprehensive record of dispensed prescriptions for each 340B client, reducing time, energy, and capital expenditures for all involved parties.
“Alteryx allows us to transfer data from independent servers into a centralized data warehouse,” commented Alan Jay Weisberg, CEO of Progressive Care. “That creates access to immediate reports from all locations, providing for decisions based on insights driven by accurate real-time information across our entire organization. Our partnership with Alteryx enables us to automate our internal processes, making our data management and data analytical teams much more efficient.”
Joe Lipski, Alteryx ACE & Analytics Leader at Aimpoint Digital commented; “At Aimpoint Digital, we were delighted to be selected as Progressive Care’s analytics partner to help accelerate their Alteryx adoption through enablement, innovation workshops and solution design. We have a passionate team of the highest skilled Alteryx users taking advantage of theAlteryx platform every day to deliver innovative and high value analytics process automation solutions across the globe.”
Recent RXMD News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 07:54:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 04:38:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2023 04:16:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:40:42 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:34:02 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 01:20:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 04:05:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/20/2023 04:04:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 01:40:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 01:37:47 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2023 01:35:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2023 04:14:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2023 08:54:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2023 08:51:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/11/2023 08:49:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 07:30:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 09:34:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/30/2023 09:33:46 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM